No Detail Found!

Comparative Analysis of Serum Proangiogenic Biomarkers Between Those with and without Diabetic Retinopathy.

Author(s)
Tayyaba Gul Malik Department of Ophthalmology, Rashid Latif Medical College, Lahore, Pakistan
Syed Shoaib Ahmed Institute of Molecular Biology and Biotechnology/Centre for Research in Molecular Medicine, The University of Lahore, Lahore, Pakistan
Roquyya Gul Institute of Molecular Biology and Biotechnology/Centre for Research in Molecular Medicine, The University of Lahore, Lahore, Pakistan
Eiman Ayesha Medical Student, Faisalabad Medical University, Faisalabad, Pakistan
Abstract
Objective: To compare the serum proangiogenic biomarkers in diabetic patients suffering from with and without diabetic retinopathy (DR). Study Design: An observational study. Place and Duration of Study: Arif Memorial Teaching Hospital, Lahore, Pakistan and Institute of Molecular Biology and Biotechnology/Centre for Research in Molecular Medicine, The University of Lahore, Lahore, Pakistan, from March to December 2017. Methodology: Forty patients with DR were included in group A and 15 patients without retinopathy (controls) were included in group B. Twelve serum pro-angiogenic biomarkers [Angiopoietin 2, Human Growth Factor (HGF), Epidermal Growth Factor (EGF), Fibroblast Growth Factor (FGF), Placental Growth Factor (PLGF), Vascular Endothelial Growth Factor-A and C (VEGF-A and VEGF-C), Bone Morphogenetic Protein 9 (BMP9), Follistatin, Leptin, Interleukin-8 (IL8), Endothelin (ET)] were analysed by xMAP flow cytometry technique, results were compared between the two groups and statistical analysis was done using Mann-Whitney U test. Results: Serum ET, Follistatin and EGF were significantly raised in group A as compared to group B having p-values of 0.001, <0.001, and 0.033, respectively. Serum BMP9, Leptin, HGF, FGF and VEGF-C had p <0.001, 0.023, 0.020, and 0.009, respectively and were higher in group B than group A. Conclusion: Serum ET, Follistatin and EGF were significantly higher in DR patients as compared to those without DR and should be considered to be significant biomarkers of retinal complications in diabetes mellitus.
Publication Details
Page(s) 686-689
DOI DOI not available
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 28, Issue: 9, Year: 2018

Request the full text from PASTIC

References
Dell'OmoR,SemeraroF,BamonteG,CifarielloF,RomanoMR,CostagliolaC, 2013.Vitreous mediators in retinal hypoxic diseases,Mediators Inflamm 16 -
GoldbergRB, 2009.Cytokine and cytokine-like inflammation markers, endothelial dysfunction, and imbalanced coagulation in development of diabetes and its complications,J Clin Endocrinol Metab 94 3171 -82
AdamisAP, 2002.Is diabetic retinopathy an inflammatory disease?,Br J Ophthalmol 86 363 -5
1991.Effects of aspirin treatment on diabetic retinopathy,ETDRS report number 8. Ophthalmology 98 757 -77
FangYH,ZhangJP,ZhouSX,ZhengJF,YuYW,YanSG, 2005.Clinical analysis of serum endothelin in type 2 diabetic patients with vascular complications,Di Yi Jun Yi Da Xue Xue Bao 25 1007 -8
MostafaMS,SamyN,AfifyM,HashemM,AzebA, 2005.Evaluation of plasma endorthelin-1 and serum inflammatory markers in patients with diabetic retinopathy,J Med Sci 5 35 -42
HansenJ,RinnovA,Krogh-MadsenR,FischerCP,AndreasenAS,BergRM, .Plasma follistatin is elevated in patients with, -
FanX,WuQ,LiY,HaoY,NingN,KangZ, 2004.Association of polymorphisms in the vascular endothelial growth factor gene and its serum levels with diabetic retinopathy in Chinese patients with type 2 diabetes: a cross-sectional study,Chin Med J (Engl) 127 651 -7
MahdyRA,NadaWM,HadhoudKM,El-TarhonySA, 2010.The role of vascular endothelial growth factor in the progression of diabetic vascular complications,Eye (Lond.) 24 1576 -84
OzturkBT,BozkurtB,KerimogluH,OkkaM,KamisU,GunduzK., 2009.Effect of serum cytokines and VEGF levels on diabetic retinopathy and macular thickness,Mol Vis 15 1906 -14
CavusogluAC,BilgiliS,AlalufA,DoganA,YilmazF,AslancaD, 2007.Vascular endothelial growth factor level in the serum of diabetic patients with retinopathy,Ann Ophthalm 39 205 -8
HuangH,HeJ,JohnsonD,WeiY,LiuY,WangS, 2015.Deletion of placental growth factor prevents diabetic retinopathy and is associated with akt activation and HIF1- VEGF pathway inhibition,Diabetes 64 200 -12
LiW,SalmonRM,JiangH, 2016.Regulation of the ALK1 ligands, BMP9 and BMP10,Biochem Soc Trans 44 1135 -41
CantonA,BurgosR,HernandezC,MateoC,SeguraR,MesaJ,SimoR, 2000.Hepatocyte growth factor in vitreous and serum from patients with proliferative diabetic retinopathy,Br J Ophthalmol 84 732 -5
KonyaH,MiuchiM,SataniK,MatsutaniS,TsunodaT,YanoY, 2014.Hepatocyte growth factor, a biomarker of macro-angiopathy in diabetes mellitus,World J Diabetes 15 678 -88
ChengX,ZhuB,JiangF,Fan H. Serum, 2011.21 levels in type 2 diabetic patients,Endocr Res 36 142 -48
LinY,XiaoY,ZhuH,XuQ,QiL,WangY, 2014.Serum fibroblast growth factor 21 levels are correlated with severity of diabetic retinopathy,J Diabetes Res 929756 -
HaffnerS,SternM,MiettinenH,WeiM,GingerichR, 1996.Leptin concentrations in diabetic and nondiabetic MexicanAmericans,Diabetes 45 822 -4
MohammadzadehG,ZarghamiN., 2013.Serum leptin level is reduced in non-obese subjects with type 2 diabetes,Int J Endocrinol Metab 11 3 -10
SunQ.,Van DamR,MeigsJ,FrancoO,MantzorosC, 2010.Leptin and soluble leptin receptor levels in plasma and risk of type 2 diabetes in U.S. women: a prospective study,Diabetes 59 611 -8
WelshP,MurrayH,BuckleyB, 2009.Leptin predicts diabetes but not cardiovascular disease: results from a large prospective study in an elderly population,Diabetes Care 32 308 -10
SheikhMH, 2017.The determinants of leptin levels in diabetic and nondiabetic Saudi males,Int J Endocrinol 3506871 -
RasulS,ReiterMH,IlhanA,LampichlerK,WagnerL,KautzkyWilleA, 2011.Circulating angiopoietin-2 and soluble Tie-2 in type 2 diabetes mellitus: a cross-scetional study,Cardiovasc Diabetol 10 55 -
LiL,QianL,YuZQ, 2015.Serum angiopoietin-2 is associated with angiopathy in type 2 diabetes mellitus,J Diabetes Complications 29 568 -571
PatelB,HiscottP,CharterisD,MatherJ,McLeodD,BoultonM. Retinal, 1994.and preretinal localisation of epidermal growth factor, transforming growth factor alpha, and their receptor in proliferative diabetic retinopathy,Br J Ophthalmol 78 714 -8
0

Citations

0

Downloads

67

Views